ehub365 Logo

Open search panel

MenuMenu

  • Pharma & Supplements
    • Singapore
    • ASEAN
    • Asia
    • Global
  • Hospitals & Doctors
    • Singapore
    • ASEAN
    • Asia
    • Global
  • Med Equipment
    • Singapore
    • ASEAN
    • Asia
    • Global
  • Complaints & Investigations
  • Health Talk
    • Pharmaceuticals & Supplements
    • Hospitals & Doctors
    • Medical Equipment
  • For Health Professionals
    • Training
    • News & Resources
  • FAQ
  • About
  • Contact
Open search panel
  1. Home
  2. Pharmaceuticals & Supplements
  3. Global Pharmaceuticals & Supplements

Global Pharmaceuticals & Supplements

HUYABIO-Reports-Positive-Phase-3-Results-for-Advanced-Melanoma-Therapy.jpg

[News Brief] HUYABIO Reports Positive Phase 3 Results for Advanced Melanoma Therapy

HUYABIO International has announced positive topline results from its global Phase 3 clinical trial evaluating HBI-8000 in combination with nivolumab…

  • ehub365.com
  • Published: July 21, 20264:24 pm
  • Author Hennah
Innovent-and-Spero-License-Anti-CD40L-Antibody-for-Autoimmune-Diseases.jpg

[News Brief] Innovent and Spero License Anti-CD40L Antibody for Autoimmune Diseases

Innovent Biologics and Spero Therapeutics have entered into an exclusive licence agreement for IBI355 (SP001), a Phase 2-ready third-generation Fc-silent…

  • ehub365.com
  • Published: July 21, 20264:23 pm
  • Author Hennah
Halozyme-and-Incyte-Partner-on-Subcutaneous-Drug-Delivery-for-Blood-Cancer-Therapy.jpg

[News Brief] Halozyme and Incyte Partner on Subcutaneous Drug Delivery for Blood Cancer Therapy

Halozyme Therapeutics has entered into a global collaboration and licence agreement with Incyte to develop subcutaneous formulations of INCA033989, a…

  • ehub365.com
  • Published: July 21, 20264:22 pm
  • Author Hennah
Sai-Parenterals-Renews-Australian-OTC-Supply-Agreement.jpg

[News Brief] Sai Parenterals Renews Australian OTC Supply Agreement

Sai Parenterals’ Australian subsidiary, Noumed Pharmaceuticals, has renewed an exclusive over-the-counter (OTC) medicines supply agreement with one of Australia’s leading…

  • ehub365.com
  • Published: July 20, 20264:23 pm
  • Author Hennah
AstraZeneca-Secures-Global-Licensing-Rights-to-Zegfrovy-for-Lung-Cancer.jpg

[News Brief] AstraZeneca Secures Global Licensing Rights to Zegfrovy for Lung Cancer

AstraZeneca has entered into an exclusive global licensing agreement with Dizal Pharmaceutical to acquire worldwide development and commercialisation rights for…

  • ehub365.com
  • Published: July 20, 20264:22 pm
  • Author Hennah
Merck-Opens-BioReliance-Testing-Facility-in-Germany.jpg

[News Brief] Merck Opens BioReliance Testing Facility in Germany

Merck has opened a 2,000-square-metre BioReliance testing facility at its headquarters in Darmstadt, Germany. The site provides commercial drug substance,…

  • ehub365.com
  • Published: July 20, 20264:21 pm
  • Author Hennah
MAXONA-Pharmaceuticals-Receives-FDA-Clearance-for-Pain-Therapy-Trial.jpg

[News Brief] MAXONA Pharmaceuticals Receives FDA Clearance for Pain Therapy Trial

MAXONA Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application…

  • ehub365.com
  • Published: July 17, 20262:56 pm
  • Author Hennah
Insilico-Medicine-Initiates-Phase-III-Trial-for-AI-Discovered-IPF-Drug-Candidate.jpg

[News Brief] Insilico Medicine Initiates Phase III Trial for AI-Discovered IPF Drug Candidate

Insilico Medicine has initiated a Phase III clinical trial evaluating Rentosertib (formerly ISM001-055/INS018_055), an orally administered small-molecule TNIK inhibitor for…

  • ehub365.com
  • Published: July 15, 20261:42 pm
  • Author Hennah
BioMed-X-and-Boehringer-Ingelheim-Expand-XSeed-Labs-Partnership.jpg

[News Brief] BioMed X and Boehringer Ingelheim Expand XSeed Labs Partnership

BioMed X and Boehringer Ingelheim have expanded their XSeed Labs collaboration by launching a new research team to advance next-generation…

  • ehub365.com
  • Published: July 15, 20261:41 pm
  • Author Hennah
West-Introduces-Synchrony-Prefillable-Syringe-System-in-Southeast-Asia.jpg

[News Brief] West Introduces Synchrony Prefillable Syringe System in Southeast Asia

West Pharmaceutical Services, Inc. has launched its Synchrony™ prefillable syringe (PFS) system for biologics and vaccines across five Southeast Asian…

  • ehub365.com
  • Published: July 15, 20261:40 pm
  • Author Hennah

Posts pagination

Page 1 Page 2 … Page 5 Next page

Recent Posts

  • [News Brief] HOYA Lens Singapore Launches MiYOSMART iQTF, Advancing Myopia Control for Children
  • Health365 Honours Cardiovascular Pioneer Prof Roger Foo in Latest Installation of “A Lifetime In Medicine” Series
  • [Press Release] Group 365Asia Launches 365asia.my to Advance Digital Healthcare Discovery and Preventive Medicine in Malaysia
  • [News Brief] Singapore-led Platform Leads Regional Collaboration for the First Successful Implantation of the World’s Smallest and Lightest Artificial Heart Assist Device
  • [News Brief] Sunway Medical Centre, Sunway City collaborates with Klinik Kesihatan Taman Medan for NHSI
A member of 365Asia.
Our additional group services are Health365, 365Asia, 健康365, 365Sehat, 365MEC
© Ehub365. All rights reserved.
scroll to top